Eevia Health Plc receives a 245 KSEK / 21 KEUR sales order for a bilberry extract
Eevia Health Plc, ("Eevia" or "The Company"), has received a sales order from a customer in Germany of c. 21 KEUR for Feno-Myrtillus® 36 Organic, an organically certified bilberry extract.
The German company is strategically focusing on health effects from Bilberry anthocyanins. The Customer's end products are branded high-end supplements with a standardized level of bilberry anthocyanins Products are sold across Germany.
The sales value to Eevia of this new order is c. KEUR 21 EUR and is the second order from a recently acquired customer. The product is Eevia's branded ingredient Feno-Myrtillus® 36 Organic, which is an organically certified bilberry extract purified and standardized with 36% anthocyanins. Bilberry anthocyanins have shown clinical benefits for humans related to eye health and metabolic conditions, among other benefits. Eevia has a strong, sustainable and socially responsible supply chain for berries harvested in the forests of Sweden and Finland.
The order is expected to be followed by further repeat orders in the future.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: [email protected]
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.
Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth
Om Eevia Health
Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.
